386 related articles for article (PubMed ID: 8872362)
1. Effects of SCA40 on human isolated bronchus and human polymorphonuclear leukocytes: comparison with rolipram, SKF94120 and levcromakalim.
Cortijo J; Villagrasa V; Navarrete C; Sanz C; Berto L; Michel A; Bonnet PA; Morcillo EJ
Br J Pharmacol; 1996 Sep; 119(1):99-106. PubMed ID: 8872362
[TBL] [Abstract][Full Text] [Related]
2. Bronchodilator and anti-inflammatory activities of SCA40: studies in human isolated bronchus, human eosinophils, and in the guinea-pig in vivo.
Cortijo J; Pons R; Dasí F; Marín N; Martinez-Losa M; Advenier C; Morcillo EJ
Naunyn Schmiedebergs Arch Pharmacol; 1997 Dec; 356(6):806-14. PubMed ID: 9453467
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of phosphodiesterase IV and intracellular calcium levels in human polymorphonuclear leukocytes.
Villagrasa V; Navarrete C; Sanz C; Berto L; Perpiñá M; Cortijo J; Morcillo EJ
Methods Find Exp Clin Pharmacol; 1996 May; 18(4):239-45. PubMed ID: 8803956
[TBL] [Abstract][Full Text] [Related]
4. Further analysis of the mechanisms underlying the tracheal relaxant action of SCA40.
Cook SJ; Archer K; Martin A; Buchheit KH; Fozard JR; Müller T; Miller AJ; Elliott KR; Foster RW; Small RC
Br J Pharmacol; 1995 Jan; 114(1):143-51. PubMed ID: 7712010
[TBL] [Abstract][Full Text] [Related]
5. Possible role of cyclic AMP phosphodiesterases in the actions of ibudilast on eosinophil thromboxane generation and airways smooth muscle tone.
Souness JE; Villamil ME; Scott LC; Tomkinson A; Giembycz MA; Raeburn D
Br J Pharmacol; 1994 Apr; 111(4):1081-8. PubMed ID: 8032594
[TBL] [Abstract][Full Text] [Related]
6. Bronchodilator and anti-inflammatory activities of glaucine: In vitro studies in human airway smooth muscle and polymorphonuclear leukocytes.
Cortijo J; Villagrasa V; Pons R; Berto L; Martí-Cabrera M; Martinez-Losa M; Domenech T; Beleta J; Morcillo EJ
Br J Pharmacol; 1999 Aug; 127(7):1641-51. PubMed ID: 10455321
[TBL] [Abstract][Full Text] [Related]
7. The effect of cyclic AMP and cyclic GMP phosphodiesterase inhibitors on the superoxide burst of guinea-pig peritoneal macrophages.
Turner NC; Wood LJ; Burns FM; Gueremy T; Souness JE
Br J Pharmacol; 1993 Apr; 108(4):876-83. PubMed ID: 8387385
[TBL] [Abstract][Full Text] [Related]
8. Suppression of eosinophil function by RP 73401, a potent and selective inhibitor of cyclic AMP-specific phosphodiesterase: comparison with rolipram.
Souness JE; Maslen C; Webber S; Foster M; Raeburn D; Palfreyman MN; Ashton MJ; Karlsson JA
Br J Pharmacol; 1995 May; 115(1):39-46. PubMed ID: 7647982
[TBL] [Abstract][Full Text] [Related]
9. Role of phosphodiesterases III and IV in the modulation of vascular cyclic AMP content by the NO/cyclic GMP pathway.
Eckly AE; Lugnier C
Br J Pharmacol; 1994 Oct; 113(2):445-50. PubMed ID: 7834194
[TBL] [Abstract][Full Text] [Related]
10. Effects of SCA40 on human bronchi and on guinea pig main bronchi in vitro. Comparison with cromakalim.
Naline E; Cui YY; Michel A; Bonnet PA; Bakdach H; Advenier C
Fundam Clin Pharmacol; 1996; 10(4):368-78. PubMed ID: 8871136
[TBL] [Abstract][Full Text] [Related]
11. Effects of SCA40 on bovine trachealis muscle and on cyclic nucleotide phosphodiesterases.
Pocock TM; Laurent F; Isaac LM; Chiu P; Elliott KR; Foster RW; Michel A; Bonnet PA; Small RC
Eur J Pharmacol; 1997 Sep; 334(1):75-85. PubMed ID: 9346331
[TBL] [Abstract][Full Text] [Related]
12. Phosphodiesterase (PDE) 7 in inflammatory cells from patients with asthma and COPD.
Jones NA; Leport M; Holand T; Vos T; Morgan M; Fink M; Pruniaux MP; Berthelier C; O'Connor BJ; Bertrand C; Page CP
Pulm Pharmacol Ther; 2007; 20(1):60-8. PubMed ID: 16427796
[TBL] [Abstract][Full Text] [Related]
13. Effect of selective phosphodiesterase type IV inhibitor, rolipram, on fluid and cellular phases of inflammatory response.
Griswold DE; Webb EF; Breton J; White JR; Marshall PJ; Torphy TJ
Inflammation; 1993 Jun; 17(3):333-44. PubMed ID: 7687237
[TBL] [Abstract][Full Text] [Related]
14. The ability of phosphodiesterase IV inhibitors to suppress superoxide production in guinea pig eosinophils is correlated with inhibition of phosphodiesterase IV catalytic activity.
Barnette MS; Manning CD; Cieslinski LB; Burman M; Christensen SB; Torphy TJ
J Pharmacol Exp Ther; 1995 May; 273(2):674-9. PubMed ID: 7752069
[TBL] [Abstract][Full Text] [Related]
15. Phosphodiesterase 4-dependent regulation of cyclic AMP levels and leukotriene B4 biosynthesis in human polymorphonuclear leukocytes.
Denis D; Riendeau D
Eur J Pharmacol; 1999 Feb; 367(2-3):343-50. PubMed ID: 10079010
[TBL] [Abstract][Full Text] [Related]
16. Investigation of the inhibitory effects of PGE2 and selective EP agonists on chemotaxis of human neutrophils.
Armstrong RA
Br J Pharmacol; 1995 Dec; 116(7):2903-8. PubMed ID: 8680723
[TBL] [Abstract][Full Text] [Related]
17. Relaxation of guinea-pig trachea by cyclic AMP phosphodiesterase inhibitors and their enhancement by sodium nitroprusside.
Turner NC; Lamb J; Worby A; Murray KJ
Br J Pharmacol; 1994 Apr; 111(4):1047-52. PubMed ID: 8032589
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of non-selective and selective phosphodiesterase inhibitors on human eosinophil functions.
Hatzelmann A; Tenor H; Schudt C
Br J Pharmacol; 1995 Feb; 114(4):821-31. PubMed ID: 7539697
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological activity of PF-904 in guinea pig in vivo, and on human bronchus and neutrophils in vitro.
Cortijo J; Martí-Cabrera M; Berto L; Antón F; Carrasco E; Grau M; Morcillo EJ
Eur J Pharmacol; 1997 Aug; 333(1):69-78. PubMed ID: 9311663
[TBL] [Abstract][Full Text] [Related]
20. Pig aortic endothelial-cell cyclic nucleotide phosphodiesterases. Use of phosphodiesterase inhibitors to evaluate their roles in regulating cyclic nucleotide levels in intact cells.
Souness JE; Diocee BK; Martin W; Moodie SA
Biochem J; 1990 Feb; 266(1):127-32. PubMed ID: 2155604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
